Championing Change: Celebrating Dr. John McLaughlin and Welcoming Dr. Jennifer Brooks
Dr. John McLaughlin will soon retire as CanPath Executive Director and has been awarded Professor Emeritus status, while Dr. Jennifer Brooks will assume the role […]
Boosting Immunity Insights: Collaborative Canadian Effort Contributes to Nationwide COVID-19 Immunity Study
TORONTO, Monday, August 14, 2023 – Today, CanPath (the Canadian Partnership for Tomorrow’s Health) has contributed to the first peer-reviewed publication showcasing pan-Canadian seroprevalence estimates – […]
CanPath at the Canadian Society for Epidemiology and Biostatistics Conference 2023
We’re so glad to have representation from Atlantic PATH, CARTaGENE, Manitoba Tomorrow Project, Ontario Health Study, and CanPath at the Canadian Society for Epidemiology and Biostatistics Conference in Halifax this week! CanPath and […]
CanPath transforming data access to unlock its full potential to improve health
New funding from Genome Canada will help CanPath build a cloud-based platform to equip researchers to understand the drivers of health and disease in Canada. […]
Healthy Future Sask Research Project Begins: Seeking 7,000 Saskatchewan Residents
The Saskatchewan Cancer Agency (SCA) is excited to announce the launch of Healthy Future Sask (HFS), a health research project that will enable future generations […]
CanPath Announces its 2023-2027 Strategic Plan
The Canadian Partnership for Tomorrow’s Health (CanPath) is excited to announce its 2023-2027 Strategic Plan! The four key objectives of this plan will guide CanPath’s […]
CanPath Awarded $1.1 million CIHR Grant for COVID-19 and Cancer Research Project
The PREPARE-Canada initiative will capture the impact of COVID-19 on cancer outcomes in Canada and the impact of COVID-19 on modifying cancer risk in the […]
20 years of Alberta’s Tomorrow Project
Alberta’s largest research platform reflects on two decades since its inception Alberta’s Tomorrow Project (ATP) launched in 2001, making history as the province’s largest health research […]
CanPath to study the impact and immune response to COVID-19 infection and vaccination
The Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study is expanding. The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task […]
Early results from CanPath’s national study confirm antibody levels are stronger after receiving two doses of COVID-19 vaccine
Initial preliminary results from the Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study, based on close to 6,000 dried blood spot samples collected between […]